Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(5):961-966. doi: 10.19540/j.cnki.cjcmm.20191230.501.
Polygoni Multiflori Radix is a commonly used traditional Chinese medicine in clinical treatment and health care. However, the related liver injury has been frequently reported, which has attracted extensive attention. Fortunately, in recent years, the scholars have made substantial progress in revealing the basic properties, main causes, material basis and molecular mechanism of Polygoni Multiflori Radix related liver injury. The basic characteristics and biomarkers of its susceptible subjects have been found. It indicated that Polygoni Multiflori Radix is only at risk of liver injury for a small number of specific subjects but safe for the majority. To provide detailed guidance for the rational use of Polygoni Multiflori Radix and related preparation, we compiled this guideline based on existing research and knowledge. The guideline has been issued by the China Association of Chinese Medicine(No. T/CACM 1328-2019).
何首乌是临床治疗和保健中常用的一味中药。然而,其相关肝损伤的报道屡见不鲜,已引起广泛关注。幸运的是,近年来,学者们在揭示何首乌相关肝损伤的基本特性、主要病因、物质基础和分子机制方面取得了重大进展。已发现其易感人群的基本特征和生物标志物。这表明何首乌仅对少数特定人群有肝损伤风险,对大多数人是安全的。为了为宜用何首乌及相关制剂提供详细指导,我们基于现有研究和知识编写了本指南。本指南已由中华中医药学会发布(编号:T/CACM 1328 - 2019)。